Skip to main content

Table 2 Characteristics of patients according to missense and loss-of-function

From: Contribution of families using the GenIDA database to the description of MED13L syndrome and literature review

Features

Missense patients

N = 24 (%)

PTV patients

N = 84 (%)

p-value

Significance

Mild intellectual disability

0/11 (0.0)

3/45 (6.7)

0.390

No

Moderate intellectual disability

5/11 (45.5)

34/45 (75.6)

0.055

No

Severe intellectual disability

6/11 (54.6)

8/45 (17.8)

0.012

Yes

Unacquired walking after 2 years of age

6/16 (37.5)

6/61 (9.8)

0.014

Yes

Age of walking achievement (months)

28.4 ± 4.1

27.2 ± 7.0

0.210

No

Absent speech

11/16 (68.8)

19/56 (33.9)

0.012

Yes

Autism

9/16 (56.3)

16/49 (32.7)

0.092

No

Seizure

8/15 (53.3)

8/52 (15.4)

0.005

Yes

Gait ataxia

4/8 (50.0)

16/31 (51.6)

1.000

No

Abnormal brain imaging

12/17 (70.6)

27/46 (58.7)

0.388

No

Hypotonia

14/17 (82.4)

51/57 (89.5)

0.420

No

Visual abnormality

12/13 (92.3)

30/33 (90.9)

0.880

No

Abnormality of cardiovascular system morphology

9/18 (50.0)

13/60 (21.7)

0.019

Yes

Bulbous nose

8/11 (72.7)

39/48 (81.3)

0.680

No

Up-slanted palpebral fissure

8/13 (61.5)

24/50 (48.0)

0.384

No

Open mouth

10/13 (76.9)

37/42 (88.1)

0.38

No

  1. PTV Premature Truncating Variants